User:Matthew Macauley - Revision history

Matthew Macauley at 02:29, 31 October 2010

2010-10-31T02:29:36Z

2010-10-31T02:18:20Z

2010-10-31T01:19:21Z

2010-10-31T01:12:27Z

2010-10-30T23:44:41Z

Created page with "Matthew Macauley received a B.Sc. from the University of British Columbia in Vancouver, Canada."

New page

Matthew Macauley received a B.Sc. from the University of British Columbia in Vancouver, Canada.

← Older revision		Revision as of 02:29, 31 October 2010
Line 1:		Line 1:
	After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the ''O''-GlcNAc modification. These studies have led to the development of potent, selective, and cell permeable inhibitors that can modulate ''O''-GlcNAc levels ''in vivo''. Currently, Matthew is continuing in the field of glycobiology in laboratory of Jim Paulson at The Scripps Research Institute as a PostDoc where he is investigating the roles of Siglecs in the immune system.		After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the ''O''-GlcNAc modification. These studies have led to the development of potent, selective, and cell permeable inhibitors that can modulate ''O''-GlcNAc levels ''in vivo''. Currently, Matthew is continuing in the field of glycobiology in laboratory of Jim Paulson at The Scripps Research Institute as a PostDoc where he is investigating the roles of Siglecs in the immune system.
		+	[[Image:filename\|thumb\|widthpx\| ]]

← Older revision		Revision as of 02:18, 31 October 2010
Line 1:		Line 1:
−	After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the ''O''-GlcNAc modification. These studies have led to the development of potent, selective, and cell permeable ~~inhibitor~~ that ~~are able to~~ modulate ''O''-GlcNAc levels in vivo. Currently, Matthew is continuing on in the field of glycobiology in laboratory of Jim Paulson at The Scripps Research Institute investigating the roles of Siglecs in the immune system.	+	After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the ''O''-GlcNAc modification. These studies have led to the development of potent, selective, and cell permeable inhibitors that can modulate ''O''-GlcNAc levels ''in vivo''. Currently, Matthew is continuing in the field of glycobiology in laboratory of Jim Paulson at The Scripps Research Institute as a PostDoc where he is investigating the roles of Siglecs in the immune system.

← Older revision		Revision as of 01:19, 31 October 2010
Line 1:		Line 1:
−	After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the O-GlcNAc modification.	+	After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the ''O''-GlcNAc modification. These studies have led to the development of potent, selective, and cell permeable inhibitor that are able to modulate ''O''-GlcNAc levels in vivo. Currently, Matthew is continuing on in the field of glycobiology in laboratory of Jim Paulson at The Scripps Research Institute investigating the roles of Siglecs in the immune system.

← Older revision		Revision as of 01:12, 31 October 2010
Line 1:		Line 1:
−	~~Matthew Macauley received~~ a B.Sc. from the University of British Columbia in Vancouver, Canada.	+	After receiving a B.Sc. in 2003 from the University of British Columbia in Vancouver, Canada, Matthew Macauley completed a PhD in 2010 at Simon Fraser University in Burnaby, Canada under the supervision of David Vocadlo. During his graduate studies, Matthew focused on the enzymes that regulate the O-GlcNAc modification.